2011 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

12 January 2011  Daniel R. Lucey MD, MPH Protecting our best weapon in treating malaria Dr Margaret Chan (Director-General of the World Health Organization) Statement at the launch of the Global Plan for Artemisinin Resistance ContainmentGeneva, Switzerland Ladies and gentlemen, The report we are launching today sets out a high-level plan to protect our most […]

2010 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

21 January 2010  Daniel R. Lucey, MD, MPH 14 Anthrax cases (7 fatal) in Scotland include some with necrotizing fasciitis and Rx with Anthrax Immunoglobulin  The number of injection drug (heroin) users in Scotland with laboratory-confirmed Bacillus anthracis infection is currently 14, with seven deaths.  The Health Protection Scotland (HPS) website, updated on a daily […]

2009 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

January 9, 2009 Daniel R. Lucey, MD, MPH No Statistically Significant Clinical Differences Seen with Oseltamivir-Resistant Influenza A (H1N1) in Norway in 2007-2008 Several media reports in the past week have commented on a possible increase in pneumonia and/or sinusitis in patients from Norway with the new oseltamivir (Tamiflu)-resistant influenza A (H1N1) virus. For example, […]

2008 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

9 January 2008 Daniel R. Lucey, MD, MPH WHO posts 42 slides on containment strategy for the initial emergence of pandemic flu The World Health Organization (WHO) posted 42 powerpoint slides, dated 7 January 2008, that provide an easily readable overview of their latest update of the interim protocol to attempt rapid containment of the […]

2007 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

4 January 2007 Daniel R. Lucey, MD, MPH US Funds Clinical Development of Peramivir, a Parenteral Neuraminidase Inhibitor Influenza Antiviral Drug On January 4 the US Department of Health and Human Services announced on their pandemic influenza website (www.pandemicflu.gov) that they had awarded a four-year contract for $102.6 million for further clinical development of the […]

2003 Center for Biologic Counter-terrorism and Emerging Diseases Forum Updates

March 13, 2003 Daniel R. Lucey, MD, MPH WHO global alert for atypical pneumonia spreading to medical persons The World Health Organization (WHO) March 12th issued a global alert (see attached file from their website) for a severe acute febrile respiratory syndrome that starts as a “flu-like” illness and has lead to respiratory failure in […]